Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1878-5085
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control ; volume:1 ; number:3 ; day:27 ; month:6 ; year:2010 ; pages:397-412 ; date:9.2010
The EPMA journal / European Association for Predictive, Preventive and Personalised Medicine ; 1, Heft 3 (27.6.2010), 397-412, 9.2010
- Creator
-
Janavicius, Ramunas
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s13167-010-0037-y
- URN
-
urn:nbn:de:1111-2016072635222
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:44 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Janavicius, Ramunas
- SpringerLink (Online service)
Other Objects (12)
BRCA1 4153delA founder mutation in Russian ovarian cancer patients
Case report: Analysis of BRCA1 and BRCA2 gene mutations in a hereditary ovarian cancer family
High frequency of BRCA1, but not CHEK2 or NBS1 (NBN), founder mutations in Russian ovarian cancer patients
Prevalence of the BRCA1 founder mutation c.5266dupin Brazilian individuals at-risk for the hereditary breast and ovarian cancer syndrome
High frequency of pathogenic non-founder germline mutations in BRCA1 and BRCA2 in families with breast and ovarian cancer in a founder population
TP53 mutations in ovarian carcinomas from sporadic cases and carriers of two distinct BRCA1 founder mutations; relation to age at diagnosis and survival
Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals
Spectrum of tumors in the families with Hereditary Breast Ovarian Cancer syndrome carrying germline mutations in BRCA1 and 2 genes
BRCA1 and BRCA2 mutations in ovarian cancer patients from Belarus: update
The Impact of BRCA1- and BRCA2 Mutations on Ovarian Reserve Status
BRCA1 founder mutations do not contribute to increased risk of gastric cancer in the Polish population
Founder mutations in BRCA1/2 are not frequent in Canadian Ashkenazi Jewish men with prostate cancer
BRCA1 4153delA founder mutation in Russian ovarian cancer patients
Case report: Analysis of BRCA1 and BRCA2 gene mutations in a hereditary ovarian cancer family
High frequency of BRCA1, but not CHEK2 or NBS1 (NBN), founder mutations in Russian ovarian cancer patients
Prevalence of the BRCA1 founder mutation c.5266dupin Brazilian individuals at-risk for the hereditary breast and ovarian cancer syndrome
High frequency of pathogenic non-founder germline mutations in BRCA1 and BRCA2 in families with breast and ovarian cancer in a founder population
TP53 mutations in ovarian carcinomas from sporadic cases and carriers of two distinct BRCA1 founder mutations; relation to age at diagnosis and survival
Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals
Spectrum of tumors in the families with Hereditary Breast Ovarian Cancer syndrome carrying germline mutations in BRCA1 and 2 genes
BRCA1 and BRCA2 mutations in ovarian cancer patients from Belarus: update
The Impact of BRCA1- and BRCA2 Mutations on Ovarian Reserve Status
BRCA1 founder mutations do not contribute to increased risk of gastric cancer in the Polish population
Founder mutations in BRCA1/2 are not frequent in Canadian Ashkenazi Jewish men with prostate cancer
BRCA1 4153delA founder mutation in Russian ovarian cancer patients
Case report: Analysis of BRCA1 and BRCA2 gene mutations in a hereditary ovarian cancer family
High frequency of BRCA1, but not CHEK2 or NBS1 (NBN), founder mutations in Russian ovarian cancer patients
Prevalence of the BRCA1 founder mutation c.5266dupin Brazilian individuals at-risk for the hereditary breast and ovarian cancer syndrome
High frequency of pathogenic non-founder germline mutations in BRCA1 and BRCA2 in families with breast and ovarian cancer in a founder population
TP53 mutations in ovarian carcinomas from sporadic cases and carriers of two distinct BRCA1 founder mutations; relation to age at diagnosis and survival
Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals
Spectrum of tumors in the families with Hereditary Breast Ovarian Cancer syndrome carrying germline mutations in BRCA1 and 2 genes
BRCA1 and BRCA2 mutations in ovarian cancer patients from Belarus: update
The Impact of BRCA1- and BRCA2 Mutations on Ovarian Reserve Status
BRCA1 founder mutations do not contribute to increased risk of gastric cancer in the Polish population